Schedule 13D ownership disclosure
OS THERAPIES INCORPORATED
Common Stock, par value $0.001 per share · CUSIP: 68764Y207
Event date: 2024-07-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Shalom AuerbachReported CIK 0002048828
Shares: 2,554,582.00 · Class: 11.9%
- Einodmil LLCReported CIK 0002048829
Shares: 2,531,211.00 · Class: 11.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-002859
- Form type
- SCHEDULE 13D
- Filer
- Auerbach Shalom
- CIK
- CIK 2048828
- Filed
- Jan 17, 2025
- Reporting period
- Jul 31, 2024
- Description
- Schedule 13D beneficial ownership